50% off all subscriptions! ... left. Order NowOrder Now

Weaker Stock
Today AGEN ranks #12758 as sell candidate. Get a Free Stock at Robinhood
Stronger Stock

Agenus Inc. Stock Forecast NASDAQ:AGEN

$3.23 (-3.29%)

Volume: 2M

Closed: Nov 26, 2021

Hollow Logo Score: -5.227

Agenus Inc. Stock Forecast

$3.23 (-3.29%)

Volume: 2M

Closed: Nov 26, 2021

Score Hollow Logo -5.227
Which way will AGEN go? Request
Key Stats
P/E Ratio 220.28
Beta 1.16
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
RSImin/max Values: [ 25 - 75 ] The Agenus Inc. stock currently holds an RSI14 at 22 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.

Evaluation of Agenus Inc. stock downgraded after the last trading session.
(Updated on Nov 26, 2021)

Sell candidate since 2021-11-10 Loss -25.40%

The Agenus Inc. stock price fell by -3.29% on the last day (Friday, 26th Nov 2021) from $3.34 to $3.23. and has now fallen 6 days in a row. During the day the stock fluctuated 6.56% from a day low at $3.20 to a day high of $3.41. The price has fallen in 8 of the last 10 days and is down by -24.18% for this period. Volume has increased on the last day by 32 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 2 million shares were bought and sold for approximately $7.52 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -45.50% during the next 3 months and, with a 90% probability hold a price between $1.43 and $2.09 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Signals & Forecast

There are few to no technical positive signals at the moment. The Agenus Inc. stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.42 and $4.30. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, November 09, 2021, and so far it has fallen -27.42%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.21 between high and low, or 6.56%. For the last week, the stock has had a daily average volatility of 6.01%.

Agenus Inc. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.

Is Agenus Inc. stock A Buy?

Agenus Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.227

Predicted Opening Price for Agenus Inc. of Monday, November 29, 2021

The predicted opening price is based on yesterday's movements between high, low, and the closing price.

Fair opening price November 29, 2021 Current price
$3.28 $3.23 (Undervalued)
Strong Sell Candidate Downgraded

Remember To Visit Our YouTube Channel

Analyst Ratings

On Oct 25, 2021 "B. Riley" gave "$12.00 - $11.00" rating for AGEN. The price target was changed from $4.01 to 21.8%.

Volatility and Risk
Daily Average Volatility: 6.01 %
Overall Risk: Very High High Medium Low Very Low
6.01 %
Daily Average Volatility
Overall Risk

Very High
Very Low

Support & Resistance

Resistance: $3.79
Price: $3.23
No Support Found

AGEN Insider Trading Show all Trades



Last 100 transactions
Buy: 8 420 830 | Sell: 463 996 (Shares)
Date Action Amount Person Type
Oct 01, 2021 Buy 4 451 Wiinberg Ulf Deferred Stock Units
Oct 01, 2021 Buy 3 257 Hirsch Susan B Common Stock
Oct 01, 2021 Buy 1 629 Wright Timothy Deferred Stock Units
Oct 01, 2021 Buy 4 560 Jordan Wadih Deferred Stock Units
Sep 13, 2021 Buy 119 178 Armen Garo H Stock Option, right to buy
Show all Insider Trades


Last 100 transactions
Buy: 8 420 830 | Sell: 463 996 (Shares)

Fibonacci Support & Resistance Levels

Level Price Change
Resistance 3.49 8.05 %
3.41 5.57 %
3.36 4.03 %
Current price: 3.23
Support 3.20 -0.94 %
3.15 -2.47 %
3.07 -4.95 %

Accumulated Volume Support & Resistance Levels

Level Price Chg %
Resistance 4.01 24.15 %
3.88 20.12 %
3.79 17.34 %
Current price 3.23
Support 0 .
0 .
0 .

Click to get the best stock tips daily for free!

About Agenus Inc.

Agenus Agenus Inc., an immuno-oncology company, focuses on the discovery and development of treatments that engage the body’s immune system for patients suffering with cancer. The company offers Retrocyte Display, an antibody discovery platform that screens and generates therapeutic antibody drug candidates using a high-throughput approach incorporating human antibody libraries expressed in mammalian B-lymphocytes. It is also developing Prophage, a hea... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 100 000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE